Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions.
Publication
, Journal Article
Han, DH; Duan, F; Patz, EF
Published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
April 2023
Published In
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
DOI
EISSN
1556-1380
ISSN
1556-0864
Publication Date
April 2023
Volume
18
Issue
4
Start / End Page
e41 / e42
Related Subject Headings
- Tomography, X-Ray Computed
- Oncology & Carcinogenesis
- Lung Neoplasms
- Lung
- Humans
- Clinical Relevance
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Han, D. H., Duan, F., & Patz, E. F. (2023). Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 18(4), e41–e42. https://doi.org/10.1016/j.jtho.2023.01.003
Han, Dae Hee, Fenghai Duan, and Edward F. Patz. “Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 18, no. 4 (April 2023): e41–42. https://doi.org/10.1016/j.jtho.2023.01.003.
Han DH, Duan F, Patz EF. Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2023 Apr;18(4):e41–2.
Han, Dae Hee, et al. “Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 18, no. 4, Apr. 2023, pp. e41–42. Epmc, doi:10.1016/j.jtho.2023.01.003.
Han DH, Duan F, Patz EF. Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2023 Apr;18(4):e41–e42.
Published In
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
DOI
EISSN
1556-1380
ISSN
1556-0864
Publication Date
April 2023
Volume
18
Issue
4
Start / End Page
e41 / e42
Related Subject Headings
- Tomography, X-Ray Computed
- Oncology & Carcinogenesis
- Lung Neoplasms
- Lung
- Humans
- Clinical Relevance
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences